Literature DB >> 32511679

The Laboratory Diagnosis of Coronavirus Disease 2019- Frequently Asked Questions.

Ferric C Fang1,2,3, Samia N Naccache4, Alexander L Greninger1.   

Abstract

Diagnostic testing has played and will continue to play a major role in the coronavirus disease 2019 (COVID-19) pandemic. The ability to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory secretions is essential to determine when an individual is infected and potentially infectious to others. Viral detection is used for the identification, management, and isolation of individual patients. Viral detection is also used to determine when the virus has entered a community and how rapidly it is spreading. As communities attempt to reopen following periods of shutdown, the detection of both SARS-CoV-2 and specific antibodies that recognize the virus will become increasingly important as a means to assess infection and immunity in individuals and communities. Here, we discuss questions commonly asked by clinicians about COVID-19 diagnostic testing.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; PCR; SARS-CoV-2; clinical microbiology; serology

Year:  2020        PMID: 32511679      PMCID: PMC7314175          DOI: 10.1093/cid/ciaa742

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.

Authors:  Samuel Pecho-Silva; Ana Claudia Navarro-Solsol; Vicky Panduro-Correa; Ali A Rabaan; Jorge L Maguiña; Alfonso J Rodriguez-Morales; Kovy Arteaga-Livias
Journal:  Chemotherapy       Date:  2021-05-07       Impact factor: 2.544

2.  Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

Authors:  Amin Addetia; Katharine H D Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

3.  Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics.

Authors:  Rosa Bellmann-Weiler; Miriam Ladstätter; Falko Schüllner; Manfred Nairz; Martina Zimmermann; Anna-Maria Koller; Silvia Blunder; Helene Naschberger; Werner Klotz; Manfred Herold; Sylvia Kerndler; Martina Jeske; David Haschka; Verena Petzer; Andrea Schroll; Thomas Sonnweber; Ivan Tancevski; Gernot Fritsche; Mariana E G de Araujo; Taras Stasyk; Lukas A Huber; Andrea Griesmacher; Igor Theurl; Günter Weiss
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  A novel ORF-1a based SARS-CoV-2 RT-PCR assay to resolve inconclusive samples.

Authors:  Ketki Jawade; Akhauri Yash Sinha; Sharad Bhagat; Shilpa Bhowmick; Bhagyashree Chauhan; Snehal Kaginkar; Harsha Palav; Nandini Kasarpalkar; Pratik Devadiga; Kalyani Karandikar; Sachee Agarwal; Jayanthi Shastri; Kiran Munne; Vikrant M Bhor; Smita D Mahale; Subhanjan Bhowmik; Dhanashree Jagtap; Vainav Patel
Journal:  Int J Infect Dis       Date:  2021-04-11       Impact factor: 3.623

5.  Health care of the elderly during Covid-19 pandemic-All a family physician should know.

Authors:  Kamal Bandhu Klanidhi; M Bhavesh; Piyush Ranjan; Avinash Chakrawarty; Shailendra S Bhadouria
Journal:  J Family Med Prim Care       Date:  2021-04-08

6.  Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.

Authors:  Suresh J Antony; Michelle A Davis; Monique G Davis; Nouf K Almaghlouth; Roberto Guevara; Fahad Omar; Fernando Del Rey; Ali Hassan; Muhammad U Arian; Nishaal Antony; Bharat V Prakash
Journal:  J Med Virol       Date:  2020-07-15       Impact factor: 20.693

7.  Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.

Authors:  Amin Addetia; Katharine Hd Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  medRxiv       Date:  2020-08-14

8.  Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.

Authors:  Sunggyun Park; Soon Hee Chang; Jae Hee Lee; Jong Ho Lee; Ji Yeon Ham; Yu Kyung Kim; Sang-Gyung Kim; Nam Hee Ryoo
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

9.  Hospital-wide antigen screening for coronavirus disease in a tertiary reference center in Sapporo, Japan: A single-center observational study.

Authors:  Yoshinosuke Shimamura; Hiroki Komazawa; Junko Oikawa; Yasushi Furuta
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

10.  Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection.

Authors:  Alpaslan Turkkan; Imran Saglik; Cansu Turan; Ahmet Sahin; Halis Akalin; Beyza Ener; Ates Kara; Solmaz Celebi; Emre Sahin; Mustafa Hacimustafaoglu
Journal:  Ir J Med Sci       Date:  2022-01-20       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.